At December s has brought together three expert leaders in their field:
Moderator Susan O Brien, MD, of Chao Family Comprehensive Cancer Center, University of California Irvine Health, is joined by Jennifer R. Brown, MD, Director of the CLL Center at Dana-Farber Cancer Institute, and Anthony Mato, MD, Director of the CLL Program at Memorial Sloan Kettering Cancer Center, for a virtual roundtable discussion on the new and potentially practice-changing data from the meeting.
In this first of four exclusive MedPage Today
episodes, the discussion centers on the studies focused on combined ibrutinib plus venetoclax therapy, including the phase II CAPTIVATE study.